Abemaciclib, Palbociclib, and Ribociclib in Real-World Data: A Direct Comparison of First-Line Treatment for Endocrine-Receptor-Positive Metastatic Breast Cancer

By the end of 2020, there were more than 8 million women alive who had received a breast cancer diagnosis in the previous 5 years, making it the most prevalent neoplasia in the world. About 70% of breast-cancer cases present positivity for estrogen and/or progesterone receptors and a lack of HER-2 o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cejuela, Mónica, Gil-Torralvo, Ana, Castilla, M. Ángeles, Domínguez-Cejudo, M. Ángeles, Falcón, Alejandro, Benavent, Marta, Molina-Pinelo, Sonia, Ruiz-Borrego, Manuel, Salvador Bofill, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217927/
https://www.ncbi.nlm.nih.gov/pubmed/37239834
http://dx.doi.org/10.3390/ijms24108488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217927/
https://www.ncbi.nlm.nih.gov/pubmed/37239834
http://dx.doi.org/10.3390/ijms24108488

Ejemplares similares